NEWS 16 JULY 2018

NEWS FROM USA

NDA Approvals

DRUG	COMPANY	Approval Date
Bortezomib (2.5 Mg) (505(b)2 Against Velcade)	Hospira Inc	12 July 2018

sNDA Approvals      

DRUG	COMPANY	Corresponding RLD	Link
Enzalutamide	Pfizer	U.S. FDA Approves enzalutamide for the Treatment of Men with Non-Metastatic Castration-Resistant Prostate Cancer

 

Other news from USFDA

FDA announces voluntary recall of several medicines containing valsartan following detection of an impurity

 

*For browsing official press releases click on the respective news item.

 

If you have any query/suggestion then please write us at pharmacaption@gmail.com